Role of natural product diversity in chemical biology

Current Opinion in Chemical Biology

Volumn 15, Issue 3, 2011, Pages 350-354

  Hong, Jiyong ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BREFELDIN A; CYCLOSPORIN A; DIAZONAMIDE A; EPOTHILONE B; ERYTHROMYCIN; EXENDIN 4; FINGOLIMOD; FUMAGILLOL CHLOROACETYLCARBAMATE; GELDANAMYCIN; IXABEPILONE; METHIONYL AMINOPEPTIDASE; NATURAL PRODUCT; OMEGA CONOTOXIN MVIIA; RAPAMYCIN; TACROLIMUS; THERMOZYMOCIDIN; TRAPOXIN A; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; BIOCHEMISTRY; BIODIVERSITY; CELL PROLIFERATION; CHEMICAL MODIFICATION; COMBINATORIAL LIBRARY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; GENOMICS; MACROMOLECULE; MOLECULAR LIBRARY; NATURAL SELECTION; PHYSICAL CHEMISTRY; PROTEIN TARGETING; REVIEW;

BIOLOGICAL PRODUCTS; CHEMISTRY; DRUG DISCOVERY; GENE EXPRESSION REGULATION; GENOMICS; SMALL MOLECULE LIBRARIES;

EID: 79958015012     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2011.03.004     Document Type: Review

References (46)

1. Schreiber S.L. The small-molecule approach to biology. Chem Eng News 2003, 81:51-61.
2. Stockwell B.R. Exploring biology with small organic molecules. Nature 2004, 432:846-854.
3. Wurdak H., Zhu S., Min K.H., Aimone L., Lairson L.L., Watson J., Chopiuk G., Demas J., Charette B., Weerapana E., Cravatt B.F., et al. A small molecule accelerates neuronal differentiation in the adult rat. Proc Natl Acad Sci U S A 2010, 107:16542-16547.
4. Bradner J.E., Mak R., Tanguturi S.K., Mazitschek R., Haggarty S.J., Ross K., Chang C.Y., Bosco J., West N., Morse E., Lin K., et al. Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. Proc Natl Acad Sci U S A 2010, 107:12617-12622.
5. Clardy J., Walsh C. Lessons from natural molecules. Nature 2004, 432:829-837.
6. Feher M., Schmidt J.M. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 2003, 43:218-227.
7. Rosén J., Gottfries J., Muresan S., Backlund A., Oprea T.I. Novel chemical space exploration via natural products. J Med Chem 2009, 52:1953-1962.
8. Firn R.D., Jones C.G. Natural products-a simple model to explain chemical diversity. Nat Prod Rep 2003, 20:382-391.
9. Bon R.S., Waldmann H. Bioactivity-guided navigation of chemical space. Acc Chem Res 2010, 43:1103-1114.
10. Dixon N., Wong L.S., Geerlings T.H., Micklefield J. Cellular targets of natural products. Nat Prod Rep 2007, 24:1288-1310.
11. McCowen M.C., Callender M.E., Lawlis J.F. Fumagillin (H-3), a new antibiotic with amebicidal properties. Science 1951, 113:202-203.
12. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., Folkman J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 1990, 348:555-557.
13. Griffith E.C., Su Z., Turk B.E., Chen S., Chang Y.H., Wu Z., Biemann K., Liu J.O. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem Biol 1997, 4:461-471.
14. Sin N., Meng L., Wang M.Q.W., Wen J.J., Bornmann W.G., Crews C.M. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci U S A 1997, 94:6099-6103.
15. Zhang Y., Griffith E.C., Sage J., Jacks T., Liu J.O. Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1. Proc Natl Acad Sci U S A 2000, 97:6427-6432.
16. Yeh J.J., Mohan R., Crews C.M. The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest. Proc Natl Acad Sci U S A 2000, 97:12782-12787.
17. Adachi K., Kohara T., Nakao N., Arita M., Chiba K., Mishina T., Sasaki S., Fujita T. Design, synthesis and structure-activity relationships of 2-substituted 2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720. Bioorg Med Chem Lett 1995, 5:853-856.
18. Mandala S., Hajdu R., Bergstrom J., Quackenbush E., Xie J., Milligan J., Thornton R., Shei G.J., Card D., Keohane C., Rosenbach M., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002, 296:346-349.
19. Brinkmann V., Davis M.D., Heise C.E., Albert R., Cottens S., Hof R., Bruns C., Prieschl E., Baumruker T., Hiestand P., Foster C.A., et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002, 277:21453-21457.
20. Brinkmann V., Cyster J.G., Hla T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 2004, 4:1019-1025.
21. Lindquist N., Fenical W., Van Duyne G.D., Clardy J. Isolation and structure determination of diazonamides A and B, unusual cytotoxic metabolites from the marine ascidian Diazona chinensis. J Am Chem Soc 1991, 113:2303-2304.
22. Lachia M., Moody C.J. The synthetic challenge of diazonamide A, a macrocyclic indole bis-oxazole marine natural product. Nat Prod Rep 2008, 25:227-253.
23. Wang G., Shang L., Burgett A.W., Harran P.G., Wang X. Diazonamide toxins reveal an unexpected function for ornithine delta-amino transferase in mitotic cell division. Proc Natl Acad Sci U S A 2007, 104:2068-2073.
24. Harvey A.L. Natural products in drug discovery. Drug Discov Today 2008, 13:894-901.
25. Ganesan A. The impact of natural products upon modern drug discovery. Curr Opin Chem Biol 2008, 12:306-317.
26. Butler M.S. Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 2008, 25:475-516.
27. Bauer R.A., Wurst J.M., Tan D.S. Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective. Curr Opin Chem Biol 2010, 14:308-314.
28. Zhang M.Q., Wilkinson B. Drug discovery beyond the 'rule-of-five'. Curr Opin Biotechnol 2007, 18:478-488.
29. Reayi A., Arya P. Natural product-like chemical space: search for chemical dissectors of macromolecular interactions. Curr Opin Chem Biol 2005, 9:240-247.
30. Wells J.A., McClendon C.L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007, 450:1001-1009.
31. Whitty A., Kumaravel G. Between a rock and a hard place?. Nat Chem Biol 2006, 2:112-118.
32. Berg T. Inhibition of transcription factors with small organic molecules. Curr Opin Chem Biol 2008, 12:464-471.
33. Arndt H.D. Small molecule modulators of transcription. Angew Chem Int Ed 2006, 45:4552-4560.
34. Payne D.J., Gwynn M.N., Holmes D.J., Pompilano D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007, 6:29-40.
35. Driggers E.M., Hale S.P., Lee J., Terrett N.K. The exploration of macrocycles for drug discovery-an underexploited structural class. Nat Rev Drug Discov 2008, 7:608-624.
36. Schreiber S.L., Crabtree G.R. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992, 13:136-142.
37. Sehgal S.N. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998, 31:335-340.
38. Goodin S., Kane M.P., Rubin E.H. Epothilones: mechanism of action and biologic activity. J Clin Oncol 2004, 22:2015-2025.
39. Schlünzen F., Zarivach R., Harms J., Bashan A., Tocilj A., Albrecht R., Yonath A., Franceschi F. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 2001, 413:814-821.
40. Kumar K., Waldmann H. Synthesis of natural product inspired compound collections. Angew Chem Int Ed Engl 2009, 48:3224-3242.
41. Nandy J.P., Prakesch M., Khadem S., Reddy P.T., Sharma U., Arya P. Advances in solution- and solid-phase synthesis toward the generation of natural product-like libraries. Chem Rev 2009, 109:1999-2060.
42. Burke M.D., Schreiber S.L. A planning strategy for diversity-oriented synthesis. Angew Chem Int Ed 2004, 43:46-58.
43. Tan D.S. Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nat Chem Biol 2005, 1:74-84.
44. Galloway W.R., Isidro-Llobet A., Spring D.R. Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. Nat Commun 2010, 1:1-13.
45. Kuruvilla F.G., Shamji A.F., Sternson S.M., Hergenrother P.J., Schreiber S.L. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature 2002, 416:653-657.
46. Koehler A.N., Shamji A.F., Schreiber S.L. Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis. J Am Chem Soc 2003, 125:8420-8421.